However, measurement of CTGF in our study showed no significant correlation between the liver fibrosis stage and the total CTGF level (Fig 4A), full-length CTGF level (Fig 4B), or N-terminal fragment level (Fig 4C) in patients with NAFLD. This evidence concerns the gene CCN2 and metabolic dysfunction-associated steatotic liver disease.